144 related articles for article (PubMed ID: 35468520)
1. CD5-positive marginal zone lymphoma: Clinicopathological features and survival outcomes.
Xia Y; Ge J; Sun Z; Nan F; Wan W; Xu D; Zhang M; Fu X
Leuk Res; 2022 Jun; 117():106840. PubMed ID: 35468520
[TBL] [Abstract][Full Text] [Related]
2. CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab.
Hsu A; Kurt H; Zayac AS; Olszewski AJ
Leuk Lymphoma; 2022 Jan; 63(1):31-42. PubMed ID: 34467833
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients.
Maeshima AM; Taniguchi H; Toyoda K; Yamauchi N; Makita S; Fukuhara S; Munakata W; Maruyama D; Kobayashi Y; Tobinai K
Br J Haematol; 2016 Sep; 174(6):923-31. PubMed ID: 27460179
[TBL] [Abstract][Full Text] [Related]
4. Value of the prognostic nutritional index (PNI) in patients with newly diagnosed, CD5-positive diffuse large B-cell lymphoma: A multicenter retrospective study of the Huaihai Lymphoma Working Group.
Ma S; Zhang B; Lu T; Li D; Li T; Shen Z; He C; Wang Y; Li B; Zhang H; Gu W; Wang C; Ye J; Zhu T; Miao Y; Wang L; Huang S; Liu Q; Sang W;
Cancer; 2022 Oct; 128(19):3487-3494. PubMed ID: 35932292
[TBL] [Abstract][Full Text] [Related]
5. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
[TBL] [Abstract][Full Text] [Related]
6. CD5 expression correlates with inferior survival and enhances the negative effect of p53 overexpression in diffuse large B-cell lymphoma.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Meng B; Zhang H
Hematol Oncol; 2019 Oct; 37(4):360-367. PubMed ID: 31359442
[TBL] [Abstract][Full Text] [Related]
7. [Transformation of CD5-positive nodal marginal zone lymphoma to diffuse large B-cell lymphoma].
Koike T; Iriyama N; Nakagawa M; Takahashi H; Hamada T; Uchino Y; Miura K; Hatta Y; Nakayama T; Takei M
Rinsho Ketsueki; 2020; 61(3):245-250. PubMed ID: 32224585
[TBL] [Abstract][Full Text] [Related]
8. Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population-based study.
Du Y; Wang Y; Li Q; Chang X; Shen K; Zhang H; Xiao M; Xing S
Int J Cancer; 2024 Mar; 154(6):969-978. PubMed ID: 37874120
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous blastic marginal zone lymphoma: A comprehensive clinical, light microscopic, phenotypic and cytogenetic appraisal.
Magro CM; Kalomeris T; Roberts A
Ann Diagn Pathol; 2023 Apr; 63():152101. PubMed ID: 36634549
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of CD5 expression in Korean patients with diffuse large B-cell lymphoma.
Kim HY; Jang MA; Kim HJ; Kim SJ; Kim WS; Kim SH
Blood Res; 2017 Sep; 52(3):193-199. PubMed ID: 29043234
[TBL] [Abstract][Full Text] [Related]
11. [CD5 expression is an adverse prognostic factor in diffuse large B-cell lymphoma].
Zheng Y; Ma XB; Jiang J; Wang YP
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):156-60. PubMed ID: 22800477
[TBL] [Abstract][Full Text] [Related]
12. Marginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report.
Hatem J; Schrank-Hacker AM; Watt CD; Morrissette JJ; Rubin AI; Kim EJ; Nasta SD; Wasik MA; Bogusz AM
Diagn Pathol; 2016 Dec; 11(1):137. PubMed ID: 27993143
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B-cell lymphoma.
Ma XB; Zhong YP; Zheng Y; Jiang J; Wang YP
Cancer Med; 2018 Sep; 7(9):4284-4295. PubMed ID: 30019388
[TBL] [Abstract][Full Text] [Related]
14. Disparity Analysis of Clinicopathologic Hallmarks between Transformed DLBCL and Primary DLBCL.
Sun C; Shen Z; Bian Z; Ma Y; Li J; Ma Y; Song X; Yan D; Liu H; Li Z; Sang W; Xu K
Clin Lab; 2022 Jul; 68(7):. PubMed ID: 35975515
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma.
Niitsu N; Okamoto M; Tamaru JI; Yoshino T; Nakamura N; Nakamura S; Ohshima K; Nakamine H; Hirano M
Ann Oncol; 2010 Oct; 21(10):2069-2074. PubMed ID: 20231297
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathological features of de novo CD5-positive diffuse large B-cell lymphoma].
Fan Y; Dong L; OUYang BS; Xu HM; Zheng SF; Wang AR; Wang CF
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):448-453. PubMed ID: 32392928
[No Abstract] [Full Text] [Related]
17. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
[TBL] [Abstract][Full Text] [Related]
18. Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature.
Magro CM; Yang A; Fraga G
Am J Dermatopathol; 2013 May; 35(3):319-26. PubMed ID: 23190506
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features of CD5-positive splenic marginal zone lymphoma.
Li Y; Wang G; Liu E; Zhang D; Zhang Y; Jian X; Zhao W; Li W
J Clin Pathol; 2024 May; 77(6):421-425. PubMed ID: 36922019
[TBL] [Abstract][Full Text] [Related]
20. De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.
Yamaguchi M; Nakamura N; Suzuki R; Kagami Y; Okamoto M; Ichinohasama R; Yoshino T; Suzumiya J; Murase T; Miura I; Ohshima K; Nishikori M; Tamaru J; Taniwaki M; Hirano M; Morishima Y; Ueda R; Shiku H; Nakamura S
Haematologica; 2008 Aug; 93(8):1195-202. PubMed ID: 18556402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]